Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,956 public trials 1,252 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC

NCT06578559

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • L'Azienda Ospedaliero Universitaria di Cagliari Monserrato, CA, Italy
  • Istituto Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" Irccs Irst Meldola, FC, Italy
  • Fondazione Casa Sollievo Della Sofferenza - Irccs San Giovanni Rotondo, FG, Italy
  • Pia Fondazione di Culto e di Religione Cardinale G. Panico Tricase, LE, Italy
View all 13 locations
View Trial Details
Active, Not Recruiting

Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

NCT03869892

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Centro de Oncología e Investigación de Buenos Aires COIBA Berazategui, Argentina
  • Hospital de Gastroenterología Dr. Carlos Borino Udaondo Oncology Unit Buenos Aires, Argentina
  • Fundación Favaloro Oncology Unit Buenos Aires, Argentina
  • Instituto Alexander Fleming Buenos Aires, Argentina
View all 190 locations
View Trial Details
Active, Not Recruiting

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT04579380

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +37 more
Locations
  • HonorHealth Phoenix, Arizona, United States
  • HonorHealth Tempe, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope at Huntington Beach Huntington Beach, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

NCT02955940

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • University of Louisville Louisville, Kentucky, United States
  • New York Oncology Hematology Pc. Clifton Park, New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details

Related conditions